Integrated DNA Technologies
Buying intent
43 tracked signals | Top 15 topics are below | Sales is carrying most of it.
Attention by team
LinkedIn activity, by teamWhere Integrated DNA Technologies's own people are actually spending their attention, by team, by topic. Bands run Low to High against the busiest pairing on this page, and each cell also shows how much of that team's own activity it represents.
Topics being researched
30-day windowEvery tracked topic, ranked by volume, not by our guess at what matters. Confidence is the classifier's own certainty that a signal belongs where we've filed it.
13d ago
19d ago
18d ago
16d ago
17d ago
16d ago
24d ago
26d ago
16d ago
25d ago
16d ago
24d ago
24d ago
24d ago
27d ago
Need intent for a specific topic or industry?
We track the full taxonomy across every account in the graph — including themes not shown on this page.
Who's active at Integrated DNA Technologies
verified title on fileTitles, seniority and topic straight from each person's own activity, with a LinkedIn link so you can check any of them yourself.
See everyone, not just the first 10
14 people across every department at Integrated DNA Technologies, plus a LinkedIn profile link for each.
Primary products / business lines
LinkedIn company profileBuilding from a strong foundation of innovation, expertise, and reliability, Integrated DNA Technologies (IDT) has evolved from an oligo manufacturer to a leading genomics provider. We work shoulder-to-shoulder with scientific and global health partners to enable genomics breakthroughs at scale. Our vision of enabling researchers to rapidly move from the lab to life-changing advances reflects our
Top accounts researching Integrated DNA Technologies
names withheld on the public pageThese are companies whose own people brought up Integrated DNA Technologies unprompted, not accounts we guessed might be interested. We can't yet tell an implementation partner from a genuine buyer here, names unlock along with the buyer profile below.
151,426 companies · 839,012 people are researching Artificial Intelligence
Integrated DNA Technologies's own team shows 3 signals on this topic. No one outside Integrated DNA Technologies has been seen researching the company by name yet — so this is the market it sits in, not a list of its buyers.
- Cyber Security13,881 cos · 59,676 people
- Drug Discovery1,689 cos · 6,442 people
Buyer profile
company size · seniorityCompany size and how senior the people involved are, the two things that decide whether this is a real deal. Competitor overlap isn't computed yet for this account.
Buying committee functions
Employee job titles (LinkedIn)Sales — 3 people; Leadership — 1 person; Marketing — 1 person; Engineering — 1 person; HR / Talent — 1 person
What's been said
public posts by Integrated DNA Technologies's teamNo public post naming Integrated DNA Technologies has surfaced in the past year, so this is what Integrated DNA Technologies's own team is posting about publicly — their topics, in their words.
Mice don't menstruate. They're also the main animal model in women's health research. Women weren't even required in clinical trials until 1993. And we wonder why AI keeps stalling on the female body. That's where last night's Women Healing Women: AI x Health panel landed for me. Hosted by Women in AI for #HumanTechWeek with Jenny D. (Clair Health), Dr. Christy Lane (FLORA Fertility), and Izzy Nova (micro1), moderated by Bidisa Mukherjee . What I'm still sitting with: ➡️ Infertility is the 3rd highest cost women face ➡️ 1 in 6 couples need fertility treatment. Only 2% can afford it. ➡️ Hormones are still modeled as homeostatic, like glucose. They're not. They're dynamic. ➡️ PCOS is being renamed to PMOS (Polyendocrine Metabolic Ovarian Syndrome) to match the biology Jenny showed how non-invasive wearables can finally feed ML models continuous hormone, sleep, stress, and ECG data — treating the female body as the dynamic system it actually is. The unlock for the next 5 years? Every panelist landed in the same place: data democratization. Pool disparate datasets. Share across companies. More women in the room. More institutional backing. Shoutout to Sarah Farrow , whose post last week made the mouse fact stick. The technology isn't the bottleneck. The data foundation is. 🧬
May 2026Amazing to see so much interest in how we’re paving the way to improved manufacturing of therapies for rare diseases. It’s going to be a packed house at the Danaher lunch session at ASGCT today!
May 2026If you need a break from the talks at ASGCT (there are so many!) drop by the exhibit hall and say hi! Team Danaher Corporation is here covering every step of the cell and gene therapy workflow.
May 2026Power demand and water use are not side notes in data center development; they are core design inputs that shape schedules, costs and community acceptance. Ray Cheatham appears on Abilene People to discuss data center projects in Texas. Watch the full episode: https://bit.ly/4eF66TA
May 2026